Document ID: chunk:federal_register_of_legislation:F2023L01745:schedule:1:p1
Version: federal_register_of_legislation:F2023L01745
Segment Type: schedule
Provision Reference: sch 1 (pt 1/42)
Character Range: 2228–5875

Schedule 1—Amendments

National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (PB 27 of 2021)
[1]           Schedule 1, entry for Abacavir with Lamivudine
    insert in the columns in the order indicated, and in alphabetical order for the column headed "Brand":
         Abacavir/Lamivudine Viatris  C4527 C4528     60  5

    [2]           Schedule 1, entry for Adalimumab in each of the forms: Injection 40 mg in 0.4 mL pre-filled pen; and Injection 40 mg in 0.4 mL pre-filled syringe
    insert in the columns in the order indicated, and in alphabetical order for the column headed "Brand":
         Adalicip  C12120 C14061 C14063 C14064 C14107 C14136     See Schedule 2  See Schedule 2

    [3]           Schedule 1, entry for Deferasirox in the form Tablet, dispersible, 125 mg
    substitute:
   Tablet, dispersible, 125 mg  Oral  Deferasirox Juno       C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7385 P8326 P8328 P8329 P9222 P9258 P9302  168  2
                                      Pharmacor Deferasirox  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7385 P8326 P8328 P8329 P9222 P9258 P9302  168  2
                                      Deferasirox Juno       C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7374 P7375                                168  5
                                      Pharmacor Deferasirox  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7374 P7375                                168  5

    [4]           Schedule 1, entry for Deferasirox in the form Tablet, dispersible, 250 mg
    substitute:
   Tablet, dispersible, 250 mg  Oral  Deferasirox Juno       C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7385 P8326 P8328 P8329 P9222 P9258 P9302  168  2
                                      Pharmacor Deferasirox  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7385 P8326 P8328 P8329 P9222 P9258 P9302  168  2
                                      Deferasirox Juno       C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7374 P7375                                168  5
                                      Pharmacor Deferasirox  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7374 P7375                                168  5

    [5]           Schedule 1, entry for Deferasirox in the form Tablet, dispersible, 500 mg
    substitute:
   Tablet, dispersible, 500 mg  Oral  Deferasirox Juno       C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7385 P8326 P8328 P8329 P9222 P9258 P9302  168  2
                                      Pharmacor Deferasirox  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7385 P8326 P8328 P8329 P9222 P9258 P9302  168  2
                                      Deferasirox Juno       C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7374 P7375                                168  5
                                      Pharmacor Deferasirox  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7374 P7375                                168  5

    [6]           Schedule 1, entry for Eculizumab
    substitute:
Eculizumab  Solution concentrate for I.V. infusion 300 mg in 30 mL  Injection  Soliris  C13458 C13459 C13464 C13560 C13660 C13661 C13684 C13845 C13857 C14750 C14753 C14754 C14781 C14792 C14793 C14799 C14805     See Schedule 2  See Schedule 2

    [7]           Schedule 1, entry for Lumacaftor with ivacaftor
    substitute:
Lumacaftor with ivacaftor  Sachet containing granules, lumacaftor 75 mg and ivacaftor 94 mg    Oral  Orkambi  C14757 C14765     See Schedule 2  See Schedule 2
                           Sachet containing granules, lumacaftor